What Can Be Done Now—and What Must Wait for Better Evidence
For a civilian prehospital blood transfusion program, the practical question is not whether it should copy another service or wait for a perfect trial. It is whether the program can meet three conditions at once: a defensible clinical indication, a reliable way to deliver the chosen product, and an honest boundary around what the evidence can support. This chapter turns those conditions into a decision model for responsible action, fallback, evaluation, and research.
A readiness decision has three tests
The first test is patient need. A program needs a defined way to recognize suspected life-threatening hemorrhagic shock rather than treating every serious injury or low blood-pressure reading as an automatic transfusion indication. The civilian coalition guideline places rapid clinical assessment at the center and points to patterns such as hypotension, a weak or absent radial pulse, persistent tachycardia, a high shock index, altered mental status, cool or pale skin, delayed capillary refill, rapid breathing, or active bleeding. It also includes medical causes such as gastrointestinal bleeding, ruptured ectopic pregnancy, peripartum hemorrhage, and ruptured aneurysm.
The purpose of a decision gate is not to turn a complex patient into a number. It is to make the threshold visible enough that trained clinicians, medical directors, receiving hospitals, and later reviewers can understand why a product was or was not given. A protocol can specify what findings count, what initial actions occur in parallel, when medical direction is required, and how special populations are handled. The guideline addresses children, pregnancy, traumatic brain injury, patients with known bleeding disorders, and people who may refuse blood for religious, cultural, social, or personal reasons. These provisions improve operational clarity, but they do not supply comparative mortality evidence for each population.
The second test is delivery readiness. A clinically indicated product has no practical value if the unit cannot be located, verified, kept within its storage requirements, warmed or administered with available equipment, or replaced without damaging the regional supply. Readiness includes the blood-bank or supplier relationship, the storage architecture, temperature monitoring, access equipment, trained personnel, medical oversight, and a receiving facility prepared to continue care. It also includes the time required to activate the pathway. A service that has blood in a cooler but cannot confirm its temperature history is not in the same state as a service with a validated and monitored unit ready for use.
The third test is evidence and learning readiness. A program does not need to know the final comparative mortality answer before treating a time-critical emergency. It does need to know what it is claiming, what it is measuring, and who is responsible for reviewing the result. The coalition guideline calls for documentation of the product, route, times, volume, patient assessment, response, adverse events, handoff, and disposition of unused products. The AHRQ review identifies data evaluation as a leverage point for implementation. Together, these requirements create a distinction between acting under uncertainty and acting without accountability.
These tests should be applied to a system, not only to an individual call. Imagine a county that has a strong blood-bank partnership and a validated cooler, but only a few clinicians have completed competency training.